In this paper is described an easily synthesized chiral diazaborolidine that is inexpensive, stable, and provides excellent stereoselection across a number of reaction classes. These versatile compounds possess utility in four different classes of cycloaddition reactions, offering good yield and stereoselectivity. X‐ray structure analysis provides insight about the origin of stereocontrol.
A catalytic conjunctive cross-coupling reaction is developed that allows the construction of chiral organoboronic esters from alkylboron ate complexes and alkyl iodide electrophiles. The process occurs most efficiently with a Ni/Pybox-comprised catalyst and with an acenapthoquinone-derived boron ligand. Because of the broad functional group tolerance of this reaction, it can be a versatile tool for organic synthesis. Applications to the construction of (R)-coniine and (−)-indolizidine 209D are described.
The Pt-catalyzed diboration of cyclic
alkenes is extended to unsaturated
heterocycles and bicyclic compounds and can be accomplished in a diastereoselective
fashion. The optimal procedures, substrate scope, and diastereoselectivity
were investigated, and examples employing both homogeneous and heterogeneous
catalysis were examined. Lastly, application to the construction of
the nucleoside analog (±)-aristeromycin was conducted.
In this paper is described an easily synthesized chiral diazaborolidine that is inexpensive, stable, and provides excellent stereoselection across a number of reaction classes. These versatile compounds possess utility in four different classes of cycloaddition reactions, offering good yield and stereoselectivity. X‐ray structure analysis provides insight about the origin of stereocontrol.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.